As expected, the USP2 inhibitor ML364 induced p53 activation and expression of its target genes (e.g., p21, PUMA, and Mdm2) in EMT6 mouse mammary tumor cells but not in isogenic p53-null EMT6 cells (Fig. 7c). The gene discussed is TP53; the disease is breast cancer.